Literature DB >> 29509236

The application of PRP combined with TCP in repairing avascular necrosis of the femoral head after femoral neck fracture in rabbit.

X-L Zhang1, Y-M Wang, K Chu, Z-H Wang, Y-H Liu, L-H Jiang, X Chen, Z-Y Zhou, G Yin.   

Abstract

OBJECTIVE: In view of the high occurrence of avascular necrosis of the femoral head (ANFH) after femoral neck fracture and the difficulties in the treatment, our work aimed to explore the effects of platelet-rich plasma (PRP) combined with tri-calcium phosphate (TCP) on the repair of ANFH after femoral neck fracture and to provide reference for clinical treatment.
MATERIALS AND METHODS: Thirty New Zealand white rabbits were randomly divided into control group, TCP group, and PRP+TCP group. The rabbit ANFH model was established and femoral head tissues were collected. HE staining was used for histological observation. Image analysis and statistical analysis were used to calculate the New Bone Area fraction (NBA %). The levels of bone morphogenetic protein (BMP)-7, transforming growth factor (TGF)-β1, basic fibroblast growth factor (bFGF), interleukin (IL)-6 and tumor necrosis factor (TNF)-a in serum were detected by Enzyme-Linked ImmunoSorbent Assay (ELISA).
RESULTS: The new bone area of TCP group was significantly lower than that of PRP+TCP group (p<0.05). Compared with the control group, the levels of BMP-7, TGF-β1 and bFGF were significantly increased in both TCP and PRP+TCP groups (p<0.05), and the increase in PRP+TCP group was higher than that in TCP group. TCP and PRP+TCP can both significantly reduce the content of IL-6 and TNF-a (p<0.05); however, higher decrease was found in PRP+TCP group compared with the TCP group at 8 weeks after injection.
CONCLUSIONS: PRP combined with TCP, which can promote new bone formation and inhibit inflammatory response, showed higher efficiency in repairing ANFH than internal fixation alone.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29509236     DOI: 10.26355/eurrev_201802_14368

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  [Research progress of tissue engineering technology in promoting revascularization of necrotic femoral bone tissue].

Authors:  Miaoyuan Lin; Jibin Yang; Wenqiang Yan; Ning Hu; Ziming Liu; Li Zhang; Yuwan Li
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-11-15

Review 2.  Bioactivation of scaffolds in osteonecrosis.

Authors:  M Jäger; A Busch; A Sowislok
Journal:  Orthopadie (Heidelb)       Date:  2022-09-08

3.  Application of Platelet-rich Plasma and Tricalcium Phosphate in the Treatment of Comminuted Fractures in Animals.

Authors:  Tomasz Szponder; Joanna Wessely-Szponder; Aleksandra Sobczyńska-Rak; Beata Żylińska; Radosław P Radzki; Izabella Polkowska
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

4.  Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis.

Authors:  Tongtong Zhu; Yutao Cui; Mingran Zhang; Duoyi Zhao; Guangyao Liu; Jianxun Ding
Journal:  Bioact Mater       Date:  2020-04-17

5.  Efficient cell transplantation combining injectable hydrogels with control release of growth factors.

Authors:  Ryo Mitsui; Makoto Matsukawa; Kiyoko Nakagawa; Emiko Isomura; Toshie Kuwahara; Teruki Nii; Susumu Tanaka; Yasuhiko Tabata
Journal:  Regen Ther       Date:  2021-09-25       Impact factor: 3.419

Review 6.  Treatment of non-traumatic avascular necrosis of the femoral head (Review).

Authors:  Ning Liu; Changming Zheng; Qinglong Wang; Zhipeng Huang
Journal:  Exp Ther Med       Date:  2022-03-10       Impact factor: 2.447

Review 7.  Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.

Authors:  Jehan J El-Jawhari; Payal Ganguly; Elena Jones; Peter V Giannoudis
Journal:  Bioengineering (Basel)       Date:  2021-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.